Melola Discovery

← Melola Discovery

Jurnal SINTA 1

The Effect of Bisoprolol on Heart Failure Preserved Ejection Fraction/HFpEF Patient’s Quality of Life

Heart Science Journal · Vol. 2 No. 4 (2021) · hlm. 25–30

DOI
10.21776/ub.hsj.2021.002.04.6
ISSN
2721-9984, 2721-9976
Terbit
2021-10-31
Penerbit
Universitas Brawijaya
Bahasa
en

Abstrak

Global Publich Health Burden of Heart Failure reported the growing prevalence of heart failure from 26 million people affected in 2017 to 64.3 million affected in 2020 worldwide with half of the case classified as heart failure preserved ejection fraction/HFpEF. It is well known that someone who have been diagnosed with heart failure will have a poorer quality of life/QoL. β-blocker is a heart rate lowering agent with a potency to improve the patient’s clinical outcome. One clinical outcome that should always be evaluated and become the main goal of the therapy is QoL of the patient. This study aimed to observe and evaluate the effect of Bisoprolol, a type of β-blocker, in the improvement of HFpEF patient’s QoL. This study is a retrospective cohort following HFpEF patients who received β-blocker and HFpEF patients who did not received β-blocker in a span of 6 months. The study participant selected by purposive sampling method. Our study found that from all HFpEF patients who received β-blocker 86 patients had a good QoL, 16 patients had a Mod QoL, and 2 patients had a poor QoL (p=0.000). Mean physical score in the patient who did not received β-blocker was 13.84±11.01 while the mean score of the patient who received β-blocker was 5.94±4.95 (p=0.000). Mean emotional score in the patient who did not received β-blocker was 6.02±6.61 while the mean score of patient who received β-blocker was 1.83±2.16 (p=0.000). We conclude that the use of Bisoprolol could improve the HFpEF patient’s QoL evaluated by total score, physical score, and emotional score.  Â

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 305 tautan kepenulisan bersama · 3 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • Universitas Trisakti
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ardian RizalUniversity of Brawijaya48
Indra PrasetyaUniversity of Brawijaya48
Cholid Tri TjahjonoUniversity of Brawijaya46
Budi SatrijoUniversity of Brawijaya39
Novi KurnianingsihUniversity of Brawijaya36
Heny MartiniUniversity of Brawijaya23
Sasmojo WiditoUniversity of Brawijaya20
Yoga WaranugrahaUniversity of Brawijaya18
Wella KarolinaUniversity of Brawijaya11
Putri Annisa KamilaUniversity of Brawijaya10
Muhammad Rizki FadlanUniversity of Brawijaya10
Valerinna YogibuanaAfiliasi tidak diketahui9
Tri AstiawatiUniversity of Brawijaya7
Olivia HandayaniUniversity of Brawijaya7
Teguh AryanugrahaUniversity of Brawijaya7
Adhika Prastya WikanandaUniversity of Brawijaya6
Nikhen NoverikeUniversity of Brawijaya6
Dadang HendrawanUniversity of Brawijaya6
Ratna PancasariUniversity of Brawijaya6
Krishna Ari NugrahaUniversity of Brawijaya6
Ferry SandraUniversitas Trisakti5
Fandy HazzyUniversity of Brawijaya5
Imelda KrisnasariUniversity of Brawijaya5
Valerinna Yogibuana Swastika PutriUniversity of Brawijaya5
Lukitasari Ayu Galuh ArdhiUniversity of Brawijaya4
Fahmy RusnantaUniversity of Brawijaya4
Oktafin Srywati PamunaUniversity of Brawijaya4
Liemena Harold AdrianUniversity of Brawijaya4
Anna Fuji RahimahAfiliasi tidak diketahui4
Lutfi Hafiz ZunardiUniversity of Brawijaya4
Cik KahadiUniversity of Brawijaya4
Imam Mi'raj SuprayogaUniversity of Brawijaya4
Hayla Iqda MillisaniUniversity of Brawijaya3
Oktivani Adelathifa RahmaUniversity of Brawijaya3
Ira Vori NugrohoUniversity of Brawijaya3

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The Effect of Bisoprolol on Heart Failure Preserved Ejection Fraction/HFpEF Patient’s Quality of Life</dc:title>
	<dc:creator xml:lang="en">Adityawati, Ayu Asri Devi</dc:creator>
	<dc:creator xml:lang="en">Rahimah, Anna Fuji</dc:creator>
	<dc:creator xml:lang="en">Rohman, Mohammad Saifur</dc:creator>
	<dc:creator xml:lang="en">Anjarwani, Setyasih</dc:creator>
	<dc:creator xml:lang="en">Sargowo, Djanggan</dc:creator>
	<dc:subject xml:lang="en">heart failure</dc:subject>
	<dc:subject xml:lang="en">bisoprolol</dc:subject>
	<dc:subject xml:lang="en">β-blocker</dc:subject>
	<dc:description xml:lang="en">Global Publich Health Burden of Heart Failure reported the growing prevalence of heart failure from 26 million people affected in 2017 to 64.3 million affected in 2020 worldwide with half of the case classified as heart failure preserved ejection fraction/HFpEF. It is well known that someone who have been diagnosed with heart failure will have a poorer quality of life/QoL. β-blocker is a heart rate lowering agent with a potency to improve the patient’s clinical outcome. One clinical outcome that should always be evaluated and become the main goal of the therapy is QoL of the patient. This study aimed to observe and evaluate the effect of Bisoprolol, a type of β-blocker, in the improvement of HFpEF patient’s QoL. This study is a retrospective cohort following HFpEF patients who received β-blocker and HFpEF patients who did not received β-blocker in a span of 6 months. The study participant selected by purposive sampling method. Our study found that from all HFpEF patients who received β-blocker 86 patients had a good QoL, 16 patients had a Mod QoL, and 2 patients had a poor QoL (p=0.000). Mean physical score in the patient who did not received β-blocker was 13.84±11.01 while the mean score of the patient who received β-blocker was 5.94±4.95 (p=0.000). Mean emotional score in the patient who did not received β-blocker was 6.02±6.61 while the mean score of patient who received β-blocker was 1.83±2.16 (p=0.000). We conclude that the use of Bisoprolol could improve the HFpEF patient’s QoL evaluated by total score, physical score, and emotional score.   </dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2021-10-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/209</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2021.002.04.6</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 2 No. 4 (2021): Management of Thrombosis in Covid-19 Patient with Cardiovascular Disease; 25-30</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2021.002.04</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/209/277</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2021 Ayu Asri Devi Adityawati</dc:rights>
</oai_dc:dc>